Edible Cannabis, Blood THC Concentrations, and Implications for Impaired Driving Policy - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Cannabis Edibles, Blood THC Levels, and Their Impact on Driving Impairment Regulations

  • By

  • José Ignacio Nazif-Munoz

  • August 31, 2026

Share

Objective:

To assess the impact of legally available Canadian cannabis edibles on simulated driving performance and evaluate the implications for cannabis-impaired driving laws.

Approach:
  • Study Design: A randomized, double-blind, placebo-controlled crossover trial was conducted with adults who regularly use cannabis.
  • Endpoints: Primary endpoint was standard deviation of lateral position; secondary endpoints included additional driving-performance measures and subjective effects.
Key Findings:
  • THC edibles caused dose-dependent deterioration in simulated driving performance.
  • Blood THC concentrations remained at or below commonly applied legal thresholds despite observed performance impairment.
  • The pharmacokinetic profile of edible cannabis complicates the interpretation of biological measures of impairment.
Interpretation:

Current models may not accurately reflect the relationship between THC levels and driving performance.

Limitations:
  • Laboratory simulators cannot fully replicate real-world driving conditions.
  • Current enforcement frameworks may not adequately account for the complexities of cannabis impairment.
Conclusion:

Future research should focus on defining circumstances of meaningful impairment and exploring a wider range of driving behaviors affected by cannabis.

Sources:

Original Source(s)

Related Content